Bibliography

Filters: Keyword is Quality-Adjusted Life Years  [Clear All Filters]
[
Alton V, Eckerlund I, Norlund A. [Health economy assessments--how to find them]. Lakartidningen. 2006;103(21-22):1726-33.
T
Drummond M. Technology assessment in the German context. Eur J Health Econ. 2007;8 Suppl 1:S3.
P
Golder S, Glanville J, Ginnelly L. Populating decision-analytic models: the feasibility and efficiency of database searching for individual parameters. Int J Technol Assess Health Care. 2005;21(3):305-11. Abstract
M
Jit M, Hutubessy R. Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible? Appl Health Econ Health Policy. 2016;14(3):245-52. Abstract
I
Dirksen CD, Utens CM, Joore MA, van Barneveld TA, Boer B, Dreesens DH, et al. Integrating evidence on patient preferences in healthcare policy decisions: protocol of the patient-VIP study. Implement Sci. 2013;8:64. Abstract
Brazier J, Ara R, Azzabi I, Busschbach J, Chevrou-Séverac H, Crawford B, et al. Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report. Value Health. 2019;22(3):267-75. Abstract
H
Fricke F-, Dauben HP. Health technology assessment: a perspective from Germany. Value Health. 2009;12 Suppl 2:S20-7.
Menon D, Stafinski T. Health technology assessment in Canada: 20 years strong? Value Health. 2009;12 Suppl 2:S14-9.
A
Drummond M, Tarricone R, Torbica A. Assessing the added value of health technologies: reconciling different perspectives. Value Health. 2013;16(1 Suppl):S7-13. Abstract